دورية أكاديمية

Correlation between Tgf-Β1 and Fsp-1 Expression in Chronic Viral Hepatitis - an Immunohistochemical Study.

التفاصيل البيبلوغرافية
العنوان: Correlation between Tgf-Β1 and Fsp-1 Expression in Chronic Viral Hepatitis - an Immunohistochemical Study.
المؤلفون: Tache DE; Biochemistry Dept., Faculty of Medicine, University of Medicine and Pharmacy of Craiova., Firu ŞG; PhD Student, Clinic of Nephrology, Emergency County Hospital No. 1 Craiova., Andrei AM; Biochemistry Dept., Faculty of Pharmacy, University of Medicine and Pharmacy of Craiova., Predescu A; Histology Dept., Faculty of Dentistry, University of Medicine and Pharmacy of Craiova., Purcaru ŞO; Biochemistry Dept., Faculty of Medicine, University of Medicine and Pharmacy of Craiova., Dobrescu AM; Genetics Dept., Faculty of Medicine, University of Medicine and Pharmacy of Craiova., Dricu A; Biochemistry Dept., Faculty of Medicine, University of Medicine and Pharmacy of Craiova., Pisoschi CG; Biochemistry Dept., Faculty of Pharmacy, University of Medicine and Pharmacy of Craiova., Stănciulescu EC; Biochemistry Dept., Faculty of Pharmacy, University of Medicine and Pharmacy of Craiova.
المصدر: Current health sciences journal [Curr Health Sci J] 2015 Apr-Jun; Vol. 41 (2), pp. 179-185. Date of Electronic Publication: 2015 Apr 10.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Medical University Publishing House Country of Publication: Romania NLM ID: 101597164 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2067-0656 (Print) NLM ISO Abbreviation: Curr Health Sci J Subsets: PubMed not MEDLINE
أسماء مطبوعة: Publication: <2013>- : Craiova : Medical University Publishing House
Original Publication: Craiova : Editura Medicală Universitară
مستخلص: Infection with hepatitis C virus (HCV) is the most important stimulus for chronic hepatitis and subsequent progression to cirrhosis and hepatocellular carcinoma. Fibrosis that follows inflammation represents the main complication. One of the mechanisms that could be associated with development of liver fibrosis is epithelial-mesenchymal transition (EMT). Transforming Growth Factor β1 (TGF-β1) is an important mediator of fibrosis and also able to trigger phenotypic changes in EMT. Fibroblast-specific protein 1 (FSP-1), a marker of fibroblasts in organs undergoing tissue remodeling, is used to identify cells that derive from EMT. In this study, we assessed the expression of TGF-β1 and FSP-1 in liver biopsies obtained from HCV-infected patients using immunohistochemistry and correlated them in order to evaluate the relation between fibrosis and EMT in liver disease progression. Staining of liver sections revealed increased amount of type III collagen and clusters of inflammatory cells invading portal spaces. The number of TGF-β1-positive cells was directly proportional to the incidence of liver injury. In cases of mild fibrosis, FSP-1 positive cells were observed in cells lining sinusoids. As fibrosis progressed, increased number of FSP-1 positive fibroblasts, isolated cholangiocytes and hepatocytes was observed. Even EMT via the activation of TGF-β signaling pathway is recognized as a pathogenic mechanism of HCV-induced liver disease, FSP-1 alone couldn't be used as a valuable marker for cells that undergo EMT.
References: Cardiovasc Res. 2007 Jul 1;75(1):40-50. (PMID: 17466960)
Am J Pathol. 2010 Feb;176(2):528-35. (PMID: 20019188)
Front Biosci. 2002 Apr 01;7:d793-807. (PMID: 11897555)
Hepatogastroenterology. 2012 Sep;59(118):1960-3. (PMID: 22369740)
J Clin Invest. 2009 Jun;119(6):1420-8. (PMID: 19487818)
Biochim Biophys Acta. 2013 Jul;1832(7):948-54. (PMID: 23470555)
J Cell Biol. 1995 Jul;130(2):393-405. (PMID: 7615639)
Am J Respir Crit Care Med. 2005 Apr 15;171(8):899-907. (PMID: 15618458)
Int J Exp Pathol. 2011 Jun;92(3):143-50. (PMID: 21554437)
Int J Mol Sci. 2014 Jun 12;15(6):10578-604. (PMID: 24927147)
Curr Opin Cell Biol. 2014 Dec;31:56-66. (PMID: 25240174)
J Clin Invest. 2005 Feb;115(2):209-18. (PMID: 15690074)
Hepatology. 2009 Dec;50(6):2007-13. (PMID: 19824076)
Am J Physiol Cell Physiol. 2013 Oct 15;305(8):C789-99. (PMID: 23903700)
Int J Med Sci. 2013;10(4):441-50. (PMID: 23471555)
J Biol Chem. 2007 Aug 10;282(32):23337-47. (PMID: 17562716)
J Hepatol. 1997 Apr;26(4):886-93. (PMID: 9126804)
Hepatology. 2010 Mar;51(3):1027-36. (PMID: 20052656)
Hum Pathol. 2008 Jan;39(1):102-15. (PMID: 17900655)
Liver Int. 2006 Feb;26(1):8-22. (PMID: 16420505)
J Clin Invest. 2009 Jun;119(6):1429-37. (PMID: 19487819)
Nig Q J Hosp Med. 2007 Jan-Mar;17(1):42-52. (PMID: 17688172)
Nat Med. 2012 Jul 06;18(7):1028-40. (PMID: 22772564)
J Virol. 2012 Dec;86(24):13621-8. (PMID: 23035229)
Rom J Morphol Embryol. 2011;52(1 Suppl):409-12. (PMID: 21424084)
J Gastrointestin Liver Dis. 2010 Dec;19(4):373-9. (PMID: 21188327)
Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):308-13. (PMID: 21173249)
Lab Invest. 2008 Feb;88(2):112-23. (PMID: 18059363)
Hepatology. 2001 Feb;33(2):387-96. (PMID: 11172340)
فهرسة مساهمة: Keywords: FSP-1; TGF-β1; epithelial-mesenchymal transition; fibrosis; hepatitis C virus
تواريخ الأحداث: Date Created: 20181027 Latest Revision: 20201001
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC6201209
DOI: 10.12865/CHSJ.41.02.14
PMID: 30364789
قاعدة البيانات: MEDLINE
الوصف
تدمد:2067-0656
DOI:10.12865/CHSJ.41.02.14